Being part of the QPS global group of companies, QPS Netherlands is a full-service CRO with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. QPS Netherlands employs over 100 people, and provides early & late phase clinical development, data management, biometrics, medical writing, bioanalysis and temporary staffing solutions. QPS Netherlands has a dedicated 34-bed clinical pharmacology unit (CPU) located at the University Medical Center Groningen (UMCG), state-of-the-art large and small molecule bioanalytical laboratories, and all the clinical (operations) support staff and capabilities necessary for the successful planning, execution, and analysis of Phase I – IV clinical trials, ranging from small studies to complex, multinational projects.